What is the AGMB stock price prediction for next 2 weeks?

According to our price prediction algorithm,AgomAb Therapeutics N.V. American Depositary Shares (AGMB) price will be around $14.53 in the next 2 weeks. This means it will increase by 8.20625465376024 from the last closing price. This prediction may vary from other time period filters for AGMB stock.

What can be the highest Possible price of AGMB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, AGMB can achieve the highest price of $15.34 which is 14.241926375309594 higher than last closing price. This prediction may vary from other time period filters for AGMB stock.

What can be the lowest Possible price of AGMB stock in next 2 weeks?

As per the forecast and algorithmic analysis, AGMB stock price can be as low as $13.75 which is 2.370271797459154 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for AGMB stock.

Will AGMB stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that AGMB stock will gain8.20625465376024 in the next 2 weeks. This prediction may vary from other time period filters for AGMB stock.

What is AGMB stock last closing price?

Last closing price of AGMB stock was $13.25.

What is AGMB stock price prediction?

AGMB stock price prediction means predicting the future closing prices of AGMB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of AGMB stock in a certain time period.

How we predict AGMB stock future prices?

If you are searching for AGMB stock forecast, analysis or price prediction, then you might be wondering what AgomAb Therapeutics N.V. American Depositary Shares (AGMB) will do in the future. Our AGMB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This AGMB price prediction will likely answer most of your questions.

How frequent we update AGMB stock predictions?

We are updating the forecasts for the AGMB stock on daily basis.

Is using ML forecasting for AGMB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for AGMB stock same for all the time periods?

No, the prediction for AGMB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

AgomAb Therapeutics N.V. American Depositary Shares Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$13.25-8.62%Since 2 Weeks

Predicted Price$14.538.21%For 2 Weeks

Upper Predicted Price$15.3414.24%For 2 Weeks

Lower Predicted Price$13.752.37%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of AGMB will rise by +8.21% over the next 2 Weeks and hit $14.53 by Thursday, September 3, 2026. In that time frame, AGMB's share price is expected to range between $13.75 and $15.34.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 3, 2026	13.75	14.53	15.34
Sep 2, 2026	13.72	14.45	15.29
Sep 1, 2026	13.72	14.50	15.25
Aug 31, 2026	13.64	14.43	15.17
Aug 28, 2026	13.35	14.09	14.81
Aug 27, 2026	13.31	14.08	14.90
Aug 26, 2026	13.27	14.00	14.72
Aug 25, 2026	13.29	14.05	14.83
Aug 24, 2026	13.23	13.97	14.74
Aug 21, 2026	12.89	13.64	14.37

AGMB shares fell -1.34% in Friday, August 21, 2026's trading session, dropping from a previous close of $13.43 to move at $13.25. The stock demonstrated notable intraday movement (see AGMB's key stats for a full breakdown), fluctuating between $13.07 and $13.64, a +4.40% trading range. While recent weeks have seen some volatility, AGMB has managed to secure a -11.67% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 68.36K shares changing hands, 23.87K fewer than the previous session. This amounted to $905.77K in total market activity.

Will AGMB Continue Its Upward Trend?

According to analyst ratings and projections for AGMB, AgomAb Therapeutics N.V. American Depositary Shares shares are anticipated to increase by +13.64%, potentially reaching $15.34 per share by September 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for AGMB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the AGMB stock forecast, now is a good time to buy AGMB stock because its current trading price is -8.82% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AGMB covering social and institutional perspectives.

AGMB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into AGMB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.57% to 50.61%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.60%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.07%, maintains a neutral outlook for the long term. Insights into AGMB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

AgomAb Therapeutics NV American Depositary Shares Short-Term Forecasts

AGMB Forecast For Next 5 Days

Our algorithm anticipates AgomAb Therapeutics NV American Depositary Shares (AGMB) stock could hit $17.35 by Aug 28, 2026. This represents a +30.96% fall from today's price, following a - change over the past five days.

AGMB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for AgomAb Therapeutics N.V. American Depositary Shares (AGMB) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $15.89, which would mean a +19.92% increase from the current price of $13.25. Projections for this period range from a high of $18.54 to a low of $13.48.

AGMB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for AgomAb Therapeutics NV American Depositary Shares's price over the next three months point to a rise. AGMB stock is expected to peak at $26.95 on Sep 14, 2026 before potentially dipping to $19.91 on Nov 13, 2026. On average, AGMB is likely to trade around $24.03 in the coming 90 days.

AgomAb Therapeutics NV American Depositary Shares Stock Forecast 2025

Based on our predictive models, AgomAb Therapeutics NV American Depositary Shares (AGMB) is expected to trade between $19.91 and $26.95 throughout 2026. This would result in an average price of $23.97, potentially offering investors a +80.91% return from current levels.

AgomAb Therapeutics N.V. American Depositary Shares Monthly Forecast 2026–2027

August 2026

According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in August 2026. The price is predicted to move between $23.97 and $26.92, settling at an average of $25.10. This could translate to a +89.43% gain.

September 2026

Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend september 2026. We forecast a trading range from $22.96 to $26.95, with a likely average price of $25.19. Investors could expect a potential return of +90.11%.

October 2026

Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in October 2026. The expected range spans $20.47–$26.48, with an average target of $23.59. This represents a positive outlook and a possible gain of +78.04%.

November 2026

Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in November 2026. Projections place the stock between $19.91 and $25.88, averaging around $23.35. This suggests a +76.23% gain from current levels.

December 2026

Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during December 2026. Prices could fluctuate within $21.76 to $25.74, with a midpoint forecast of $23.45. The stock might deliver a +76.98% gain.

January 2027

Forecasting for January 2027, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $21.31 and $24.78, averaging $22.96. This signals a positive trajectory with potential returns around +73.28%.

February 2027

According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in February 2027. The price is predicted to move between $20.91 and $22.66, settling at an average of $21.71. This could translate to a +63.85% gain.

March 2027

Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend march 2027. We forecast a trading range from $16.45 to $22.41, with a likely average price of $18.62. Investors could expect a potential return of +40.53%.

April 2027

Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in April 2027. The expected range spans $13.93–$18.72, with an average target of $16.41. This represents a positive outlook and a possible gain of +23.85%.

May 2027

Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in May 2027. Projections place the stock between $16.26 and $18.25, averaging around $17.10. This suggests a +29.06% gain from current levels.

June 2027

Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during June 2027. Prices could fluctuate within $14.18 to $16.63, with a midpoint forecast of $15.47. The stock might deliver a +16.75% gain.

July 2027

Forecasting for July 2027, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $13.86 and $16.84, averaging $15.49. This signals a positive trajectory with potential returns around +16.91%.

August 2027

According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in August 2027. The price is predicted to move between $15.86 and $17.25, settling at an average of $16.49. This could translate to a +24.45% gain.

AGMB's history of dividends and stock splits also plays a role in long-term investor confidence.